Related Experiment Videos
Neuroprotective agents in acute ischemic stroke
1Stanford University, Department of Neurology and Neurological Sciences, Stanford Stroke Center, Palo Alto, California, USA.
The Journal of Cardiovascular Nursing
|October 24, 1998
Summary
Brain ischemia creates a window for neuroprotection. Neuroprotective agents may help viable neurons in the ischemic penumbra recover, offering a chance for improved stroke patient care.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Background:
- Brain ischemia, or stroke, leads to rapid neuronal death.
- The ischemic penumbra, a region with collateral circulation, contains viable neurons that can be saved.
- A critical window exists between stroke onset and irreversible brain damage.
Purpose of the Study:
- To review mechanisms of ischemic neuronal injury.
- To discuss the mechanism of action of neuroprotective agents.
- To summarize current clinical trials and patient care guidelines for neuroprotection.
Main Methods:
- Literature review of scientific data on brain ischemia.
- Analysis of neuroprotective agent mechanisms.
- Compilation of information on clinical trials and patient management.
Main Results:
- Neurons in the ischemic penumbra can survive for hours post-stroke.
- Neuroprotective agents show potential for salvaging these viable neurons.
- Understanding injury mechanisms informs therapeutic strategies.
Conclusions:
- Targeting the ischemic penumbra with neuroprotective agents is a promising therapeutic approach.
- Further clinical trials are essential to establish efficacy and optimize patient care.
- Effective management of stroke patients involves timely intervention and neuroprotection.